MiRNA expression analysis in cortical dysplasia: Regulation of mTOR and LIS1 pathway

Epilepsy Research

Volumn 108, Issue 3, 2014, Pages 433-441

  Lee, Ji Yeoun ^a   Park, Ae Kyung ^b   Lee, Eun Sun ^a   Park, Woong Yang ^c,d   Park, Sung Hye ^e   Choi, Jung Won ^a   Phi, Ji Hoon ^a   Wang, Kyu Chang ^a   Kim, Seung Ki ^a  

^a Seoul National University Children's Hospital   (South Korea)

^b Sunchon National University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Samsung Medical Center   (South Korea)

^e Seoul National University Hospital   (South Korea)

Author keywords

Cortical dysplasia; LIS1; Microarray; MiRNA; MTOR

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 130B; MICRORNA 139 3P; MICRORNA 155; MICRORNA 193A 3P; MICRORNA 193B; MICRORNA 199B 5P; MICRORNA 21; MICRORNA 532 5P; MICRORNA 572; MICRORNA 877; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ADOLESCENT; AGYRIA; AKT GENE; ARTICLE; CELL MIGRATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; EIF4B GENE; ENZYME REGULATION; FEMALE; GENE; GENE TARGETING; HIF1ALPHA GENE; HUMAN; HUMAN TISSUE; LIS1 GENE; LKB1 GENE; MALE; MO25 GENE; NERVE CELL DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PIK3R1 GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTEN GENE; REAL TIME POLYMERASE CHAIN REACTION; RHEB GENE; RICTOR GENE; RSK GENE; SCHOOL CHILD; SIGNAL TRANSDUCTION; TSC1 GENE; UPREGULATION; VEGF GENE;

CORTICAL DYSPLASIA; LIS1; MICROARRAY; MIRNA; MTOR;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFANT; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MICRORNAS; MICROTUBULE-ASSOCIATED PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84895425702     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2014.01.005     Document Type: Article

References (36)

1. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136.
2. Baybis M., Yu J., Lee A., Golden J.A., Weiner H., McKhann G., Aronica E., Crino P.B. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Annals of Neurology 2004, 56:478-487.
3. Becker A.J., Urbach H., Scheffler B., Baden T., Normann S., Lahl R., Pannek H.W., Tuxhorn I., Elger C.E., Schramm J., Wiestler O.D., Blumcke I. Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Annals of Neurology 2002, 52:29-37.
4. Bentivoglio M., Tassi L., Pech E., Costa C., Fabene P.F., Spreafico R. Cortical development and focal cortical dysplasia. Epileptic Disorders 2003, 5(Suppl. 2):S27-S34.
5. Blumcke I., Vinters H.V., Armstrong D., Aronica E., Thom M., Spreafico R. Malformations of cortical development and epilepsies: neuropathological findings with emphasis on focal cortical dysplasia. Epileptic Disord 2009, 11:181-193.
6. Blumcke I., Thom M., Aronica E., Armstrong D.D., Vinters H.V., Palmini A., Jacques T.S., Avanzini G., Barkovich A.J., Battaglia G., Becker A., Cepeda C., Cendes F., Colombo N., Crino P., Cross J.H., Delalande O., Dubeau F., Duncan J., Guerrini R., Kahane P., Mathern G., Najm I., Ozkara C., Raybaud C., Represa A., Roper S.N., Salamon N., Schulze-Bonhage A., Tassi L., Vezzani A., Spreafico R. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011, 52:158-174.
7. Bronen R.A., Vives K.P., Kim J.H., Fulbright R.K., Spencer S.S., Spencer D.D. Focal cortical dysplasia of Taylor, balloon cell subtype: MR differentiation from low-grade tumors. American Journal of Neuroradiology 1997, 18:1141-1151.
8. Cleator S.J., Powles T.J., Dexter T., Fulford L., Mackay A., Smith I.E., Valgeirsson H., Ashworth A., Dowsett M. The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis. Breast Cancer Research 2006, 8:R32.
9. Cotter D.R., Honavar M., Everall I. Focal cortical dysplasia: a neuropathological and developmental perspective. Epilepsy Research 1999, 36:155-164.
10. Crino P.B. Focal brain malformations: seizures, signaling, sequencing. Epilepsia 2009, 50(Suppl. 9):3-8.
11. D'Arcangelo G. From human tissue to animal models: insights into the pathogenesis of cortical dysplasia. Epilepsia 2009, 50(Suppl. 9):28-33.
12. Debey S., Schoenbeck U., Hellmich M., Gathof B.S., Pillai R., Zander T., Schultze J.L. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. The Pharmacogenomics Journal 2004, 4:193-207.
13. Dobyns W.B., Reiner O., Carrozzo R., Ledbetter D.H. Lissencephaly. A human brain malformation associated with deletion of the LIS1 gene located at chromosome 17p13. The Journal of the American Medical Association 1993, 270:2838-2842.
14. European Chromosome 16 Tuberous Sclerosis C. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993, 75:1305-1315.
15. Fassunke J., Blumcke I., Lahl R., Elger C.E., Schramm J., Merkelbach-Bruse S., Mathiak M., Wiestler O.D., Becker A.J. Analysis of chromosomal instability in focal cortical dysplasia of Taylor's balloon cell type. Acta Neuropathologica 2004, 108:129-134.
16. Fingar D.C., Salama S., Tsou C., Harlow E., Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes & Development 2002, 16:1472-1487.
17. Gomez-Anson B., Thom M., Moran N., Stevens J., Scaravilli F. Imaging and radiological-pathological correlation in histologically proven cases of focal cortical dysplasia and other glial and neuronoglial malformative lesions in adults. Neuroradiology 2000, 42:157-167.
18. Kim S.K., Wang K.C., Hong S.J., Chung C.K., Lim S.Y., Kim Y.Y., Chi J.G., Kim C.J., Chung Y.N., Kim H.J., Cho B.K. Gene expression profile analyses of cortical dysplasia by cDNA arrays. Epilepsy Research 2003, 56:175-183.
19. Krsek P., Maton B., Korman B., Pacheco-Jacome E., Jayakar P., Dunoyer C., Rey G., Morrison G., Ragheb J., Vinters H.V., Resnick T., Duchowny M. Different features of histopathological subtypes of pediatric focal cortical dysplasia. Annals of Neurology 2008, 63:758-769.
20. Kwon C.H., Zhu X., Zhang J., Baker S.J. mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:12923-12928.
21. Lee J.H., Huynh M., Silhavy J.L., Kim S., Dixon-Salazar T., Heiberg A., Scott E., Bafna V., Hill K.J., Collazo A., Funari V., Russ C., Gabriel S.B., Mathern G.W., Gleeson J.G. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nature Genetics 2012, 44:941-945.
22. Liu J.S., Schubert C.R., Walsh C.A. Rare genetic causes of lissencephaly may implicate microtubule-based transport in the pathogenesis of cortical dysplasias. Jasper's Basic Mechanisms of the Epilepsies 2012, Oxford University Press, Bethesda, MD. 4th ed. J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (Eds.).
23. Ljungberg M.C., Bhattacharjee M.B., Lu Y., Armstrong D.L., Yoshor D., Swann J.W., Sheldon M., D'Arcangelo G. Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Annals of Neurology 2006, 60:420-429.
24. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
25. Miyata H., Chiang A.C., Vinters H.V. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Annals of Neurology 2004, 56:510-519.
26. Palmini A., Gambardella A., Andermann F., Dubeau F., da Costa J.C., Olivier A., Tampieri D., Robitaille Y., Paglioli E., Paglioli Neto E., et al. Operative strategies for patients with cortical dysplastic lesions and intractable epilepsy. Epilepsia 1994, 35(Suppl. 6):S57L 71.
27. Palmini A., Najm I., Avanzini G., Babb T., Guerrini R., Foldvary-Schaefer N., Jackson G., Luders H.O., Prayson R., Spreafico R., Vinters H.V. Terminology and classification of the cortical dysplasias. Neurology 2004, 62:S2-S8.
28. Papagiannakopoulos T., Shapiro A., Kosik K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Research 2008, 68:8164-8172.
29. Schick V., Majores M., Engels G., Hartmann W., Elger C.E., Schramm J., Schoch S., Becker A.J. Differential Pi3K-pathway activation in cortical tubers and focal cortical dysplasias with balloon cells. Brain Pathology 2007, 17:165-173.
30. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 2004, 3:Article3.
31. Teng G., Papavasiliou F.N. Shhh! Silencing by microRNA-155. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences 2009, 364:631-637.
32. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., Galuppo P., Just S., Rottbauer W., Frantz S., Castoldi M., Soutschek J., Koteliansky V., Rosenwald A., Basson M.A., Licht J.D., Pena J.T., Rouhanifard S.H., Muckenthaler M.U., Tuschl T., Martin G.R., Bauersachs J., Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984.
33. van Slegtenhorst M., de Hoogt R., Hermans C., Nellist M., Janssen B., Verhoef S., Lindhout D., van den Ouweland A., Halley D., Young J., Burley M., Jeremiah S., Woodward K., Nahmias J., Fox M., Ekong R., Osborne J., Wolfe J., Povey S., Snell R.G., Cheadle J.P., Jones A.C., Tachataki M., Ravine D., Sampson J.R., Reeve M.P., Richardson P., Wilmer F., Munro C., Hawkins T.L., Sepp T., Ali J.B., Ward S., Green A.J., Yates J.R., Kwiatkowska J., Henske E.P., Short M.P., Haines J.H., Jozwiak S., Kwiatkowski D.J. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997, 277:805-808.
34. Wong M. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia 2010, 51:27-36.
35. Wong M. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations. Experimental Neurology 2013, 244:22-26.
36. Wynshaw-Boris A., Pramparo T., Youn Y.H., Hirotsune S. Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies. Seminars in Cell & Developmental Biology 2010, 21:823-830.